Hem › Plattenepitelcancer i huvud och hals › Virginia › Arlington
Kliniska studier för Plattenepitelcancer i huvud och hals i Arlington, VA
26 studier för Plattenepitelcancer i huvud och hals söker deltagare vid platser i och runt Arlington (inom ca 30 miles). Öppna en studie för att se vem som kan delta och hur du kontaktar studieteamet.
Officiell studietext (engelska)
Rekryterar du till en studie? Visa den högst upp på sidan – $99 i 30 dagar →
A Phase 1, First-in-Human (FIH), Open-Label, Dose-Escalation and Dose Expansion Study of the Peptide Drug Conjugate (PDC), TS-104, as a Monotherapy in Subjects With Select Advanced Solid Tumors
RekryterarFas 1
- Site 04, Fairfax · 11 mi bort
A First in Human Study of ALX2004 With Advanced or Metastatic Selected Solid Tumors
RekryterarFas 1
- ALX Center 2, Fairfax · 11 mi bort
A Study of Amivantamab in Addition to Standard of Care Agents (SOC) Compared With SOC Alone in Participants With Recurrent/Metastatic Head and Neck Cancer
RekryterarFas 3
- Virginia Cancer Specialists, Fairfax · 11 mi bort
A Study of Amivantamab Alone or in Addition to Other Treatment Agents in Participants With Head and Neck Cancer
RekryterarFas 1/2
- Virginia Cancer Specialists, Fairfax · 11 mi bort
BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study
RekryterarFas 2
- Inova Fairfax Hospital, Falls Church · 4 mi bort
- Inova Schar Cancer Institute, Fairfax · 11 mi bort
- Inova Fair Oaks Hospital, Fairfax · 11 mi bort
Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors
RekryterarFas 1
- Virginia Cancer Specialists, Fairfax · 11 mi bort
A Study of ASP388B Given by Itself and With Standard Therapies in Participants With Solid Tumors
RekryterarFas 1/2
- NEXT Virginia, Fairfax · 11 mi bort
A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations
RekryterarFas 1/2
- NEXT Oncology, Fairfax · 11 mi bort
A Study to See if Giving Fianlimab and Cemiplimab Together is Better Than Cemiplimab Alone at Treating Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
RekryterarFas 2
- Inova Schar Cancer Institute, Fairfax · 11 mi bort
A Study to Investigate Safety of AZD6750 in Adult Participants With Select Advanced or Metastatic Solid Tumors
RekryterarFas 1/2
- Research Site, Fairfax · 11 mi bort
A Phase 1 Study of NRM-823 in Participants With Locally Advanced or Metastatic Refractory Solid Tumors
RekryterarFas 1
- Normunity Investigational Site, Fairfax · 11 mi bort
A Study of DM005 in Patients With Advanced Solid Tumors
RekryterarFas 1/2
- NEXT Oncology Virginia, Fairfax · 11 mi bort
A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)
RekryterarFas 1/2
- Virginia Cancer Specialists, Fairfax · 11 mi bort
A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors
RekryterarFas 1
- NEXT Virginia, Fairfax · 11 mi bort
First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors
RekryterarFas 1/2
- USO-Virginia Cancer Specialists, PC, Fairfax · 11 mi bort
A Study of Sigvotatug Vedotin in Advanced Solid Tumors
RekryterarFas 1
- Virginia Cancer Specialists, Fairfax · 11 mi bort
A Study to Investigate ALE.P02 as Monotherapy in Adult Patients With Selected CLDN1+ Solid Tumors
RekryterarFas 1/2
- NEXT Oncology Virginia, Fairfax · 11 mi bort
Phase 1/2 Study of ETX-636 in Participants With Advanced Solid Tumors
RekryterarFas 1/2
- NEXT, Fairfax · 11 mi bort
Study to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma and Other Solid Tumors, Receiving Intravenous Infusion of Azirkitug Alone or in Combination(s) With Budigalimab, Bevacizumab, or Telisotuzumab Adizutecan
RekryterarFas 1
- Virginia Cancer Specialists - Fairfax /ID# 232592, Fairfax · 11 mi bort
A Study of IDE034 in Adult Participants With Locally Advanced/Metastatic Solid Tumors Types
RekryterarFas 1
- NEXT Texas LLC - Virginia, Fairfax · 11 mi bort
A Study of DB-1310 in Advanced/Metastatic Solid Tumors
RekryterarFas 1/2
- NEXT Virginia, Fairfax · 11 mi bort
Study of CP-383 in Patients With Advanced or Metastatic Solid Tumors
RekryterarFas 1/2
- NEXT Virginia, Fairfax · 11 mi bort
A Study of DR-0202 in Patients With Locally Advanced or Metastatic, Relapsed or Refractory Carcinomas
RekryterarFas 1
- Dren Investigational Site, Fairfax · 11 mi bort
Study to Evaluate LB-LR1109, Administered Alone for the Treatment of Solid Tumor and in Combination With Atezolizumab for the Treatment of NSCLC
RekryterarFas 1
- NEXT Oncology, Fairfax · 11 mi bort
A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors
RekryterarFas 1/2
- Research Site 102, Fairfax · 11 mi bort
- Research Site 112, Fairfax · 11 mi bort
A Clinical Study of Intratumoral MVR-T3011 (T3011) Given as a Single Agent and in Combination With Intravenous Pembrolizumab in Participants With Advanced or Metastatic Solid Tumors
RekryterarFas 1/2
- Virginia Cancer Specialists, Fairfax · 11 mi bort
Plattenepitelcancer i huvud och hals-studier i andra städer
- Houston, TX47 studier
- Los Angeles, CA42 studier
- Boston, MA40 studier
- New York City, NY39 studier
- Nashville, TN39 studier
- St. Louis, MO28 studier
- Philadelphia, PA26 studier
- Chicago, IL26 studier
- Atlanta, GA24 studier
- San Antonio, TX22 studier
- New Haven, CT22 studier
- Pittsburgh, PA22 studier
Andra studier i Arlington
- Icke-småcellig lungcancer104 studier
- Metastaserande cancer53 studier
- Kolorektal cancer52 studier
- Cancer (alla typer)48 studier
- Bröstcancer47 studier
- Äggstockscancer46 studier
- Lungcancer41 studier
- Endometriecancer39 studier
- Bukspottkörtelcancer33 studier
- Småcellig lungcancer23 studier
- Magsäckscancer20 studier
- Triplenegativ bröstcancer20 studier
Från ClinicalTrials.gov, data hämtad 6 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.